SpadCare: digital home-care program for patients with PICC lines
Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience
This program tests a smartphone app that teaches and remotely monitors adults with PICC lines who receive home infusions to help reduce catheter complications.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 201 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fundacion Miguel Servet Academic / other |
| Locations | 1 site (Pamplona, Navarre) |
| Trial ID | NCT06905119 on ClinicalTrials.gov |
What this trial studies
The project uses a smartphone app (SpadCare) to deliver training and real-time support for adults with peripherally inserted central catheters (PICC) receiving home infusions or parenteral nutrition. Patients perform guided self-care and report symptoms through the app while the Infusion and Vascular Access Team monitors status remotely via telemedicine. The intervention aims to improve adherence to catheter-care procedures and enable earlier detection of catheter-related complications to reduce infections and unplanned healthcare visits. Enrollment is limited to consenting adults with a PICC placed by the University Hospital of Navarra and planned use of at least one month.
Who should consider this trial
Good fit: Adults (≥18) with a PICC placed by the University Hospital of Navarra's Infusion and Vascular Access Team, planning at least one month of use, who own a smartphone, consent to the app, and allow access to their electronic medical record.
Not a fit: Patients without a smartphone or sufficient digital skills, those who refuse to install the app or to authorize medical-record access, or patients treated outside the enrolling center may not receive benefit.
Why it matters
Potential benefit: If successful, the program could lower PICC-related infections and complications, reduce hospital visits, and improve patient confidence in managing home infusions.
How similar studies have performed: Prior telemedicine and mobile app interventions for catheter and home-infusion care have shown promising but variable reductions in complications and improved self-care in smaller studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \>18 years. * Sign the informed consent form. * Have a Smartphone and accept the use of the APP. * Patient with a PICC inserted by the Infusion and Vascular Access Team of the University Hospital of Navarra and with a planned use of at least one month. Exclusion Criteria: * Patients with limitations in the use of digital resources or lack of Smartphone. * Patients who do not want to install the APP on their Smartphone * Patients who do not authorize access to their Computerized Medical Record (HCI).
Where this trial is running
Pamplona, Navarre
- Hospital Universitario de Navarra — Pamplona, Navarre, Spain (Recruiting)
Study contacts
- Study coordinator: María Inés Corcuera Martínez MI Corcuera Martínez, RN-PhD(c)
- Email: mi.corcuera.martinez@navarra.es
- Phone: +34 687609658
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.